307 related articles for article (PubMed ID: 8968960)
1. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.
Atassi MZ; Dolimbek BZ; Hayakari M; Middlebrook JL; Whitney B; Oshima M
J Protein Chem; 1996 Oct; 15(7):691-700. PubMed ID: 8968960
[TBL] [Abstract][Full Text] [Related]
2. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
Atassi MZ; Jankovic J; Steward LE; Aoki KR; Dolimbek BZ
Immunobiology; 2012 Jan; 217(1):17-27. PubMed ID: 21962573
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.
Atassi MZ; Dolimbek BZ
Protein J; 2004 Jan; 23(1):39-52. PubMed ID: 15115181
[TBL] [Abstract][Full Text] [Related]
4. Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains.
Atassi MZ; Oshima M; Dolimbek BZ; Aoki KR
Immunobiology; 2012 Jan; 217(1):1-7. PubMed ID: 22015045
[TBL] [Abstract][Full Text] [Related]
5. Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin.
Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
Mol Immunol; 2008 Feb; 45(4):910-24. PubMed ID: 17897717
[TBL] [Abstract][Full Text] [Related]
6. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
Dolimbek GS; Dolimbek BZ; Aoki KR; Atassi MZ
Immunol Invest; 2005; 34(2):119-42. PubMed ID: 15921155
[TBL] [Abstract][Full Text] [Related]
7. Localization of the regions on the C-terminal domain of the heavy chain of botulinum A recognized by T lymphocytes and by antibodies after immunization of mice with pentavalent toxoid.
Rosenberg JS; Middlebrook JL; Atassi MZ
Immunol Invest; 1997 Jun; 26(4):491-504. PubMed ID: 9246568
[TBL] [Abstract][Full Text] [Related]
8. Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin.
Oshima M; Hayakari M; Middlebrook JL; Atassi MZ
Mol Immunol; 1997 Oct; 34(14):1031-40. PubMed ID: 9488054
[TBL] [Abstract][Full Text] [Related]
9. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
Atassi MZ; Dolimbek GS; Deitiker PR; Aoki KR; Dolimbek BZ
Mol Immunol; 2005 Aug; 42(12):1509-20. PubMed ID: 15950744
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
Shi DY; Lu JS; Mao YY; Liu FJ; Wang R; Du P; Yu S; Yu YZ; Yang ZX
Appl Microbiol Biotechnol; 2023 May; 107(10):3205-3216. PubMed ID: 37058230
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A.
Dolimbek BZ; Aoki KR; Steward LE; Jankovic J; Atassi MZ
Mol Immunol; 2007 Feb; 44(5):1029-41. PubMed ID: 16647121
[TBL] [Abstract][Full Text] [Related]
12. Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
Atassi MZ; Dolimbek BZ; Jankovic J; Steward LE; Aoki KR
Mol Immunol; 2008 Sep; 45(15):3878-88. PubMed ID: 18676021
[TBL] [Abstract][Full Text] [Related]
13. Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins.
Atassi MZ; Oshima M
Crit Rev Immunol; 1999; 19(3):219-60. PubMed ID: 10422600
[TBL] [Abstract][Full Text] [Related]
14. Regions of recognition by blocking antibodies on the light chain of botulinum neurotoxin A: antigenic structure of the entire toxin.
Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
Immunobiology; 2011 Jun; 216(6):698-706. PubMed ID: 21183243
[TBL] [Abstract][Full Text] [Related]
15. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
Dolimbek BZ; Jankovic J; Atassi MZ
Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
[TBL] [Abstract][Full Text] [Related]
16. Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action.
Atassi MZ; Dolimbek BZ; Steward LE; Aoki KR
Crit Rev Immunol; 2007; 27(4):319-41. PubMed ID: 18197812
[TBL] [Abstract][Full Text] [Related]
17. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
[TBL] [Abstract][Full Text] [Related]
18. A peptide-based immunoassay for antibodies against botulinum neurotoxin A.
Atassi MZ; Dolimbek BZ; Deitiker P; Jankovic J; Aoki KR
J Mol Recognit; 2007; 20(1):15-21. PubMed ID: 16981247
[TBL] [Abstract][Full Text] [Related]
19. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW
Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
[TBL] [Abstract][Full Text] [Related]
20. Development of an Equine Antitoxin by Immunizing the Halla Horse with the Receptor-Binding Domain of Botulinum Neurotoxin Type A1.
Kim NY; Park KE; Lee YJ; Kim YM; Hong SH; Son WR; Hong S; Lee S; Ahn HB; Yang J; Seo JP; Lim YK; Yu CH; Hur GH; Jeong ST; Lee HS; Song K; Kang TJ; Shin YK; Choi JS; Choi JY
J Microbiol Biotechnol; 2019 Jul; 29(7):1165-1176. PubMed ID: 31280529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
